Diese Veranstaltung hat bereits stattgefunden

Web-Seminar

MACULA 2021

The Johns Hopkins Wilmer Eye Institute CME Activity
online, USA
Veranstaltungsnummer: 34778
Gebühren ab: gebührenfrei
verfügbare Plätze: unbegrenzt
Sprache: Deutsch

 Zum Kalender hinzufügen
  • Datum
    23.01.2021, 13:30 - 00:00
    Veranstalter
    The Johns Hopkins Wilmer Eye Institute
    Kurzbeschreibung
    Over the past several years, there is a growing body of medical evidence demonstrating a clear biologic rationale for targeting vascular endothelial growth factors in the treatment of the neovascular form of agerelated macular degeneration, diabetic retinopathy, and related diseases.
    Gebühren

    Fachärzte

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    kostenlos
    Hinweis
    k.A.

    Ärzte/-innen in Weiterbildung

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    kostenlos
    Hinweis
    k.A.

    Studenten/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    kostenlos
    Hinweis
    k.A.
  • Furthermore, there are new imaging and therapeutic approaches to vitreomacular interface abnormalities, intraocular tumors, posterior uveitis, hereditary retinal degenerations, as well as surgical diseases of the retina. These areas of investigation are relatively new, and most ophthalmologists are not aware of the myriad of new clinical trials relevant to these diseases. Thus, these subjects are areas of great interest both to ophthalmologists who treat these diseases and to those who refer these cases for further management. Presentations were chosen to emphasize new information and consensus on the use of these biologic agents to treat the neovascular and non-neovascular forms of age-related macular degeneration, vitreomacular interface abnormalities, diabetic retinopathy, intraocular tumors, and posterior uveitis. In addition, cases were chosen highlighting new information being reported by randomized clinical trials in these disease areas.

    Objectives
    • Recognize the role of anti-angiogenic treatments for eyes with choroidal neovascularization from age-related macular degeneration or diabetic retinopathy, including proliferative diabetic retinopathy and diabetic macular edema.
    • Evaluate recent clinical studies evaluating treatments for hereditary retinal degenerations.
    • Recognize the role of imaging in the management of vitreomacular interface abnormalities.
    • Review the current and emerging therapeutic approaches for surgical retinal diseases.
    • Summarize the evidence of surgical and medical treatments for intraocular tumors.
    • Detect which patients are appropriate for biologic treatments of posterior uveitis.
  • This events takes place virtualy

    The Johns Hopkins Wilmer Eye Institute
    Center of Excellence for Ophthalmic Surgical Education and Training
    600 North Wolfe Street
    US - MD 21287 Baltimore

  • Registration required. Please contact the organizer for further information.